Cargando…

The migalastat GLP-HEK assay is the gold standard for determining amenability in patients with Fabry disease

Detalles Bibliográficos
Autores principales: Schiffmann, Raphael, Bichet, Daniel G., Benjamin, Elfrida, Wu, Xiaoyang, Giugliani, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656697/
https://www.ncbi.nlm.nih.gov/pubmed/31367522
http://dx.doi.org/10.1016/j.ymgmr.2019.100494
_version_ 1783438666524262400
author Schiffmann, Raphael
Bichet, Daniel G.
Benjamin, Elfrida
Wu, Xiaoyang
Giugliani, Roberto
author_facet Schiffmann, Raphael
Bichet, Daniel G.
Benjamin, Elfrida
Wu, Xiaoyang
Giugliani, Roberto
author_sort Schiffmann, Raphael
collection PubMed
description
format Online
Article
Text
id pubmed-6656697
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-66566972019-07-31 The migalastat GLP-HEK assay is the gold standard for determining amenability in patients with Fabry disease Schiffmann, Raphael Bichet, Daniel G. Benjamin, Elfrida Wu, Xiaoyang Giugliani, Roberto Mol Genet Metab Rep Letter to the Editor Elsevier 2019-07-19 /pmc/articles/PMC6656697/ /pubmed/31367522 http://dx.doi.org/10.1016/j.ymgmr.2019.100494 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Schiffmann, Raphael
Bichet, Daniel G.
Benjamin, Elfrida
Wu, Xiaoyang
Giugliani, Roberto
The migalastat GLP-HEK assay is the gold standard for determining amenability in patients with Fabry disease
title The migalastat GLP-HEK assay is the gold standard for determining amenability in patients with Fabry disease
title_full The migalastat GLP-HEK assay is the gold standard for determining amenability in patients with Fabry disease
title_fullStr The migalastat GLP-HEK assay is the gold standard for determining amenability in patients with Fabry disease
title_full_unstemmed The migalastat GLP-HEK assay is the gold standard for determining amenability in patients with Fabry disease
title_short The migalastat GLP-HEK assay is the gold standard for determining amenability in patients with Fabry disease
title_sort migalastat glp-hek assay is the gold standard for determining amenability in patients with fabry disease
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656697/
https://www.ncbi.nlm.nih.gov/pubmed/31367522
http://dx.doi.org/10.1016/j.ymgmr.2019.100494
work_keys_str_mv AT schiffmannraphael themigalastatglphekassayisthegoldstandardfordeterminingamenabilityinpatientswithfabrydisease
AT bichetdanielg themigalastatglphekassayisthegoldstandardfordeterminingamenabilityinpatientswithfabrydisease
AT benjaminelfrida themigalastatglphekassayisthegoldstandardfordeterminingamenabilityinpatientswithfabrydisease
AT wuxiaoyang themigalastatglphekassayisthegoldstandardfordeterminingamenabilityinpatientswithfabrydisease
AT giuglianiroberto themigalastatglphekassayisthegoldstandardfordeterminingamenabilityinpatientswithfabrydisease
AT schiffmannraphael migalastatglphekassayisthegoldstandardfordeterminingamenabilityinpatientswithfabrydisease
AT bichetdanielg migalastatglphekassayisthegoldstandardfordeterminingamenabilityinpatientswithfabrydisease
AT benjaminelfrida migalastatglphekassayisthegoldstandardfordeterminingamenabilityinpatientswithfabrydisease
AT wuxiaoyang migalastatglphekassayisthegoldstandardfordeterminingamenabilityinpatientswithfabrydisease
AT giuglianiroberto migalastatglphekassayisthegoldstandardfordeterminingamenabilityinpatientswithfabrydisease